+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Gender Dysphoria - Pipeline Insight, 2025 - Product Thumbnail Image

Gender Dysphoria - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
GNE Myopathy - Pipeline Insight, 2025 - Product Thumbnail Image

GNE Myopathy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cannabis Use Disorder (CUD) - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabis Use Disorder (CUD) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Congenital Heart Defect - Pipeline Insight, 2025 - Product Thumbnail Image

Congenital Heart Defect - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Abdominal Aneurysms - Pipeline Insight, 2025 - Product Thumbnail Image

Abdominal Aneurysms - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
GM1 Gangliosidosis - Pipeline Insight, 2025 - Product Thumbnail Image

GM1 Gangliosidosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acute Gout Flare - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Gout Flare - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hidradenitis - Pipeline Insight, 2025 - Product Thumbnail Image

Hidradenitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HET Obesity/POMC Deficiency Obesity - Pipeline Insight, 2025 - Product Thumbnail Image

HET Obesity/POMC Deficiency Obesity - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Herpes Genitalis - Pipeline Insight, 2025 - Product Thumbnail Image

Herpes Genitalis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Heavy Menstrual Bleeding (HMB) - Pipeline Insight, 2025 - Product Thumbnail Image

Heavy Menstrual Bleeding (HMB) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hair Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Hair Diseases - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
mGlu5 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

mGlu5 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
PDE 10 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

PDE 10 Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Lumbosacral Radicular Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Lumbosacral Radicular Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Moderate To Severe Acne - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Acne - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Neuropathic Pruritus & Postburn Itch - Pipeline Insight, 2025 - Product Thumbnail Image

Neuropathic Pruritus & Postburn Itch - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Obese Patients With Schizophrenia - Pipeline Insight, 2025 - Product Thumbnail Image

Obese Patients With Schizophrenia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
PD-1 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Primary Mitochondrial Myopathies - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Mitochondrial Myopathies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more